Sofia Tavani

Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study

P. Barbanti, G. Egeo, C. Aurilia, 2024, Journal of neurology.